phentermine has been researched along with sibutramine in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (12.50) | 18.2507 |
| 2000's | 20 (62.50) | 29.6817 |
| 2010's | 8 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Borrell, L; Foreyt, JP; Haddock, CK; Poston, WS | 1 |
| Apovian, CM | 1 |
| Aronne, LJ; Hirsch, J; Mackintosh, RM | 1 |
| Birkeland, KI; Tonstad, S | 1 |
| Aspley, S; Butler, SA; Dykes, SG; Heal, DJ; Kilpatrick, IC; Prow, MR; Rowley, HL | 1 |
| Ballmer, PE; Imoberdorf, R | 1 |
| Francis, GS | 1 |
| Hanif, MW; Kumar, S | 1 |
| Gura, T | 1 |
| Arfken, CL; Johanson, CE; Schuster, CR | 1 |
| Jones, SL; Miller, DK; Wellman, PJ | 1 |
| Li, Z; Maggard, M; Maglione, M; Mojica, WA; Morton, SC; Shekelle, PG; Shugarman, L; Solomon, V; Suttorp, M; Tu, W | 1 |
| Arterburn, D | 2 |
| Cheng, D; Chi, CL; Gan, J; Han, S; Largent, BL; O'Tanyi, EJ; Rohrbach, KW; Taub, R; Zhang, H | 1 |
| Alemany, M; Cabot, C; Fernández-López, JA; Ferrer-Lorente, R; Remesar, X | 1 |
| Arterburn, D; DeLaet, D; Flum, D | 1 |
| Dixon, JB | 1 |
| Pi-Sunyer, FX | 1 |
| Alisky, JM | 1 |
| Azarisman, SM; Magdi, YA; Noorfaizan, S; Oteh, M | 1 |
| Athanacio, J; Coffey, T; Kesty, NC; Lei, C; Mack, C; Parkes, DG; Roth, JD; Trevaskis, JL; Weyer, C; Wilson, J | 1 |
| Aronne, LJ; Burns, CM; Halseth, AE; Miller, S; Shen, LZ | 1 |
| Kaplan, LM | 1 |
| Goldfine, AB; Hiatt, WR; Thomas, A | 1 |
| Hubičková Heringová, L; Kralova, T; Manakova, E | 1 |
| Block, JP; Brennan, TA; Carpenter, DP; Choudhry, NK; Fischer, MA; Matlin, OS; Shrank, WH; Tong, AY | 1 |
| Baretić, M | 1 |
| Berghold, A; Horvath, K; Jeitler, K; Meschik, J; Posch, N; Semlitsch, T; Siebenhofer, A | 1 |
15 review(s) available for phentermine and sibutramine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Challenges in obesity management.
Topics: 1-Naphthylamine; Adrenergic beta-Agonists; Appetite Depressants; Behavior Therapy; Caffeine; Cyclobutanes; Diethylpropion; Ephedrine; Fenfluramine; Fluoxetine; Humans; Lactones; Leptin; Lipase; Obesity; Orlistat; Phentermine; Proteins; Sertraline | 1998 |
The use of pharmacologic agents in the treatment of the obese patient.
Topics: Anti-Obesity Agents; Body Mass Index; Cyclobutanes; Female; Follow-Up Studies; Humans; Lactones; Male; Obesity; Orlistat; Phentermine; Weight Loss | 1999 |
[The obesity epidemics--do diet pills have a place in the treatment?].
Topics: Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Fenfluramine; Humans; Lactones; Leptin; Obesity; Obesity, Morbid; Orlistat; Phentermine; Selective Serotonin Reuptake Inhibitors; Weight Loss | 2000 |
[Obesity: principles of drug therapy].
Topics: Aminorex; Anti-Obesity Agents; Appetite Depressants; Chronic Disease; Combined Modality Therapy; Cyclobutanes; Dexfenfluramine; Diet, Reducing; Drug and Narcotic Control; Germany; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Lactones; Obesity; Orlistat; Phentermine | 2000 |
Pharmacological management of obesity.
Topics: Anti-Obesity Agents; Appetite Depressants; Clinical Trials as Topic; Cyclobutanes; Humans; Lactones; Methylcellulose; Obesity; Orlistat; Phentermine | 2002 |
Pharmacological and surgical treatment of obesity.
Topics: Adult; Appetite Depressants; Bupropion; Cyclobutanes; Diethylpropion; Fluoxetine; Fructose; Gastric Bypass; Gastroplasty; Humans; Lactones; Lipase; Obesity; Orlistat; Phentermine; Topiramate | 2004 |
Obesity.
Topics: Adult; Appetite Depressants; Cyclobutanes; Diethylpropion; Fluoxetine; Humans; Lactones; Mazindol; Obesity; Orlistat; Phentermine; Phenylpropanolamine | 2003 |
Obesity.
Topics: Adult; Appetite Depressants; Cyclobutanes; Diethylpropion; Fluoxetine; Humans; Lactones; Mazindol; Obesity; Orlistat; Phentermine; Phenylpropanolamine; Selective Serotonin Reuptake Inhibitors | 2004 |
Obesity.
Topics: Adult; Appetite Depressants; Cyclobutanes; Diethylpropion; Fluoxetine; Gastric Bypass; Gastroplasty; Humans; Lactones; Mazindol; Obesity; Orlistat; Phentermine | 2005 |
Weight loss medications--where do they fit in?
Topics: Anti-Obesity Agents; Chronic Disease; Cyclobutanes; Diethylpropion; Humans; Lactones; Obesity; Orlistat; Phentermine; Weight Loss | 2006 |
Use of lifestyle changes treatment plans and drug therapy in controlling cardiovascular and metabolic risk factors.
Topics: Caloric Restriction; Cardiovascular Diseases; Cyclobutanes; Diabetes Mellitus; Diet; Diet, Fat-Restricted; Diet, Mediterranean; Exercise; Feeding Behavior; Food, Formulated; Humans; Lactones; Metabolic Syndrome; Obesity; Orlistat; Phentermine; Prediabetic State; Risk Reduction Behavior; Weight Loss | 2006 |
Pharmacologic therapies for obesity.
Topics: Anti-Obesity Agents; Appetite Depressants; Bariatric Surgery; Benzazepines; Bupropion; Cyclobutanes; Ephedrine; Fenfluramine; Humans; Lactones; Naltrexone; Obesity; Orlistat; Phentermine; Weight Gain; Weight Loss | 2010 |
Obesity drug therapy.
Topics: Anti-Obesity Agents; Appetite; Combined Modality Therapy; Comorbidity; Cost-Benefit Analysis; Cyclobutanes; Diabetes Mellitus, Type 2; Diet, Diabetic; Drug Combinations; Exercise Therapy; Fructose; Gastrointestinal Hormones; Humans; Incretins; Insulin; Insulin Secretion; Intestines; Lactones; Leptin; Life Style; Models, Biological; Neuropeptides; Obesity; Orlistat; Phentermine; Phytotherapy; Piperidines; Plant Preparations; Pyrazoles; Rimonabant; Topiramate | 2013 |
Long-term effects of weight-reducing drugs in people with hypertension.
Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Blood Pressure; Cyclobutanes; Diet, Reducing; Female; Fructose; Humans; Hypertension; Lactones; Male; Middle Aged; Orlistat; Phentermine; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Safety-Based Drug Withdrawals; Time; Topiramate; Weight Loss | 2016 |
2 trial(s) available for phentermine and sibutramine
| Article | Year |
|---|---|
The effects of drugs used to treat obesity on the autonomic nervous system.
Topics: Adrenergic beta-Antagonists; Adult; Appetite Depressants; Atropine; Autonomic Nervous System; Basal Metabolism; Calorimetry; Creatinine; Cyclobutanes; Dexfenfluramine; Dopamine; Epinephrine; Heart Rate; Humans; Male; Norepinephrine; Obesity; Parasympatholytics; Phentermine; Propanolamines; Serotonin Receptor Agonists; Single-Blind Method | 2000 |
Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial.
Topics: Adolescent; Adult; Appetite Depressants; Blood Pressure; Cyclobutanes; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypoglycemic Agents; Islet Amyloid Polypeptide; Male; Middle Aged; Obesity; Phentermine; Single-Blind Method; Weight Loss; Young Adult | 2010 |
15 other study(ies) available for phentermine and sibutramine
| Article | Year |
|---|---|
Studies confirm link between fen-phen and heart-valve disease.
Topics: Appetite Depressants; Cyclobutanes; Dexfenfluramine; Drug Combinations; Fenfluramine; Heart Valve Diseases; Humans; Obesity; Phentermine | 1998 |
Orlistat for obesity.
Topics: Anti-Obesity Agents; Appetite Depressants; Clinical Trials as Topic; Cyclobutanes; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Fees, Pharmaceutical; Humans; Intestinal Absorption; Lactones; Lipase; Obesity; Orlistat; Phentermine | 1999 |
Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats.
Topics: Animals; Appetite Depressants; Central Nervous System Stimulants; Cyclobutanes; Dextroamphetamine; Dopamine; Eating; Male; Motor Activity; Nucleus Accumbens; Phentermine; Rats; Rats, Sprague-Dawley | 2000 |
I have tried everything I can think of to lose weight on my own and am now thinking of using weight-loss medications. Are they safe?
Topics: Appetite Depressants; Cyclobutanes; Drug Combinations; Humans; Phentermine; Weight Loss | 2002 |
Obesity drug pipeline not so fat.
Topics: Agouti-Related Protein; alpha-MSH; Animals; Anti-Obesity Agents; Appetite; Arcuate Nucleus of Hypothalamus; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Energy Intake; Ghrelin; Humans; Hunger; Intercellular Signaling Peptides and Proteins; Lactones; Leptin; Mice; Nerve Tissue Proteins; Neurons; Neuropeptide Y; Obesity; Orlistat; Peptide Fragments; Peptide Hormones; Peptide YY; Phentermine; Proteins; Receptors, Corticotropin; Receptors, Melanocortin; Weight Loss | 2003 |
Postmarketing surveillance of abuse liability of sibutramine.
Topics: Adult; Appetite Depressants; Cyclobutanes; Female; Humans; Male; Phentermine; Product Surveillance, Postmarketing; Substance Abuse Treatment Centers; Substance-Related Disorders; Surveys and Questionnaires | 2003 |
Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Appetite Depressants; Body Weight; Cyclobutanes; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Eating; Fenfluramine; Fluoxetine; Male; Norepinephrine; Phentermine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2003 |
Disconnection between the early onset anorectic effects by C75 and hypothalamic fatty acid synthase inhibition in rodents.
Topics: 4-Butyrolactone; Animals; Appetite Depressants; Behavior, Animal; Blotting, Northern; Cyclobutanes; Dose-Response Relationship, Drug; Fatty Acid Synthases; Fenfluramine; Food Deprivation; Hypothalamus; Immunoblotting; Injections, Intraperitoneal; Injections, Intraventricular; Kinetics; Male; Phentermine; Random Allocation; Rats; Rats, Inbred F344; RNA; Time Factors | 2005 |
Effects of oleoyl-estrone with dexfenfluramine, sibutramine or phentermine on overweight rats.
Topics: Animals; Anti-Obesity Agents; Body Weight; Cyclobutanes; Dexfenfluramine; Drug Interactions; Drug Therapy, Combination; Energy Metabolism; Estrone; Insulin; Lipids; Male; Obesity; Oleic Acids; Phentermine; Rats; Rats, Wistar | 2005 |
Phentermine, sibutramine and metformin could be used for the prevention and treatment of steroid-induced weight gain.
Topics: Adrenergic Agents; Appetite Depressants; Cyclobutanes; Humans; Hypoglycemic Agents; Metformin; Phentermine; Steroids; Weight Gain | 2007 |
Myocardial infarction induced by appetite suppressants in Malaysia.
Topics: Adult; Appetite Depressants; Cyclobutanes; Electrocardiography; Female; Humans; Malaysia; Myocardial Infarction; Phentermine | 2007 |
Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
Topics: Amyloid; Animals; Anti-Obesity Agents; Body Composition; Body Weight; Cyclobutanes; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eating; Gene Expression Profiling; Gene Expression Regulation; Islet Amyloid Polypeptide; Male; Motor Activity; Obesity; Phentermine; Rats; Rats, Sprague-Dawley | 2008 |
What cost weight loss?
Topics: Anti-Obesity Agents; Benzazepines; Bupropion; Cyclobutanes; Fructose; Humans; Naltrexone; Obesity; Phentermine; Risk Assessment; Risk Factors; Topiramate; Weight Loss | 2012 |
Appetite suppressants in pregnancy.
Topics: Abnormalities, Multiple; Abortion, Spontaneous; Appetite Depressants; Cyclobutanes; Czech Republic; Databases, Factual; Drug Prescriptions; Female; Humans; Obesity; Phentermine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prevalence; Prospective Studies; Risk Factors | 2012 |
Time series analyses of the effect of FDA communications on use of prescription weight loss medications.
Topics: Adolescent; Adult; Aged; Anti-Obesity Agents; Appetite Depressants; Cohort Studies; Cyclobutanes; Drug Utilization; Female; Humans; Lactones; Male; Middle Aged; Obesity; Orlistat; Phentermine; United States; United States Food and Drug Administration; Weight Loss; Young Adult | 2014 |